Complement Factor B (CFB) inhibits the malignant progression of lung adenocarcinoma by downregulating the Ras/MAPK signaling pathway.

Lung adenocarcinoma (LUAC) as the most common lung cancer, and its incidence is increasing. Complement factor B (CFB) is an important factor in the alternative complement pathway. CFB has been reported to be involved in the progression of many cancers, including in pancreatic cancer, cutaneous squamous cell carcinoma, and nasopharyngeal carcinoma, but the function and molecular mechanism of CFB in LUAC remains unclear.

Prediction of different stages of rectal cancer: Texture analysis based on diffusion-weighted images and apparent diffusion coefficient maps.

Background: It is evident that an accurate evaluation of T and N stage rectal cancer is essential for treatment planning. It has not been extensively investigated whether texture features derived from diffusion-weighted imaging (DWI) images and apparent diffusion coefficient (ADC) maps are associated with the extent of local invasion (pathological stage T1-2 T3-4) and nodal involvement (pathological stage N0 N1-2) in rectal cancer.

Aim: To predict different stages of rectal cancer using texture analysis based on DWI images and ADC maps.

Transcriptome analysis reveals gender-specific differences in overall metabolic response of male and female patients in lung adenocarcinoma.

Background: Evidence from multiple studies suggests metabolic abnormalities play an important role in lung cancer. Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer. The present study aimed to explore differences in the global metabolic response between male and female patients in LUAD and to identify the metabolic genes associated with lung cancer susceptibility.